ABP
Abpro Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.52
+0.00%Latest reported
- Last report date
- Nov 14, 2025
- EPS actual
- -$0.63
- EPS estimate
- -$1.20
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +47.5%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 14, 2025